GE Healthcare Issues $1.25 Billion in Senior Notes

GE Healthcare Technologies Inc ( (GEHC) ) just unveiled an update.

On December 12, 2025, GE Healthcare Technologies Inc. entered into a three-year senior unsecured term loan credit facility for $750 million, with JPMorgan Chase Bank as the administrative agent. This agreement includes various covenants and is aimed at supporting the company’s financial operations. Additionally, on December 15, 2025, GE Healthcare issued $1.25 billion in senior notes to finance its acquisition of Intelerad Medical Systems, marking a strategic expansion in its healthcare solutions portfolio. The notes are set to mature in 2028 and 2035, respectively, and are part of the company’s broader financial strategy to enhance its market positioning.

The most recent analyst rating on (GEHC) stock is a Hold with a $88.00 price target. To see the full list of analyst forecasts on GE Healthcare Technologies Inc stock, see the GEHC Stock Forecast page.

Spark’s Take on GEHC Stock

According to Spark, TipRanks’ AI Analyst, GEHC is a Outperform.

GE Healthcare Technologies Inc. demonstrates strong financial performance and a positive outlook from the latest earnings call, despite facing cash flow challenges and tariff impacts. The technical indicators suggest a neutral trend, while the valuation appears fair. The company’s strategic initiatives and raised guidance contribute positively to the overall score.

To see Spark’s full report on GEHC stock, click here.

More about GE Healthcare Technologies Inc

GE Healthcare Technologies Inc. operates in the healthcare industry, focusing on providing advanced medical technologies and services. The company is known for its innovative solutions in medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, catering to a global market.

Average Trading Volume: 3,613,058

Technical Sentiment Signal: Strong Buy

Current Market Cap: $38.25B

For an in-depth examination of GEHC stock, go to TipRanks’ Overview page.